Sign In

Rachel Knight

Director of Business Development at Amgen

Professional Background

Rachel Knight is a seasoned professional with extensive experience in the lifesciences and healthcare industries. With a strong focus on drug development and commercialization, Rachel has cultivated a diverse skill set that encompasses aspects ranging from pharmaceutical revenue forecasting to medical device sales force optimization and strategic planning. Currently, she serves as the Director of Business Development at Amgen, where she plays an instrumental role in shaping the future of innovative biopharmaceuticals.

Before joining Amgen, Rachel honed her skills at L.E.K. Consulting, a prestigious consulting firm known for its expertise in healthcare strategy. Here, she served as a Senior Associate Consultant, providing valuable insights and strategic guidance to clients in the life sciences sector. Her work at L.E.K. allowed her to develop a robust understanding of market dynamics and the critical factors that influence drug development strategies. This experience laid the foundation for her transition to the business side of healthcare, where she now excels.

Throughout her career, Rachel has held various key positions at Amgen, including Director of General Medicine Forecasting and Strategic Planning and Operations Senior Manager. Her responsibilities have included developing forecasting models for major pharmaceutical products such as Enbrel, Senispar, and Parsabiv. Her expertise in secondary analytics has enabled her to deliver actionable insights that drive business growth and inform strategic decision-making.

Education and Achievements

Rachel knighted her academic endeavors at esteemed institutions that have significantly shaped her professional trajectory. She earned her Master’s Degree in Business of Biosciences from the Keck Graduate Institute of Applied Life Sciences. This rigorous program equipped Rachel with the knowledge and skills necessary to navigate the complex landscape of life sciences business. Her education at Keck focused on fostering innovation and developing strategic thinking, which have been integral to her success in the pharmaceutical industry.

Prior to her graduate studies, Rachel completed her Bachelor of Arts at the University of Chicago, a leading institution known for its commitment to academic excellence and robust inquiry-based learning. During her time at the University of Chicago, Rachel engaged deeply in biological sciences research, which enriched her understanding of scientific principles and research methodologies.

Achievements

Rachel's achievements extend beyond her formal education. Her career trajectory showcases a series of progressive roles that reflect her dedication and expertise in the lifesciences sector. As a Director of Business Development at Amgen, Rachel is responsible for identifying growth opportunities and shaping strategic partnerships that align with Amgen’s commitment to scientific innovation and improved patient outcomes.

At Amgen, her previous positions have equipped her with a wealth of experience in forecasting, strategic planning, and operations. Notably, her role in forecasting for products such as Enbrel, Senispar, and Parsabiv has directly impacted Amgen's market strategy, ensuring the company remains at the forefront of the industry. Rachel's contributions to benchmarking molecular diagnostics strategies further illustrate her comprehensive approach to business development in the life sciences realm.

In addition to her strategic roles, Rachel's earlier experiences as a research assistant at the University of Chicago and her internships have solidified her foundational understanding of both clinical and commercial aspects of biopharmaceuticals. Her time as a Managed Markets Intern at Campbell Alliance provided her with firsthand exposure to the intricacies of market access, enhancing her capability to drive commercial strategies effectively.

Rachel Knight's journey illustrates her unwavering commitment to the fields of life sciences and healthcare. Through her educational background and professional accomplishments, she exemplifies the fusion of scientific inquiry and business acumen. As she continues her work at Amgen and in the broader healthcare landscape, Rachel remains dedicated to advancing drug development and ensuring that innovative therapies reach patients in need.

Related Questions

How did Rachel Knight transition from clinical research to business development in the pharmaceutical industry?
What specific skills did Rachel Knight acquire during her Master's Degree at the Keck Graduate Institute that have contributed to her success at Amgen?
In her role at Amgen, how does Rachel Knight utilize forecasting to influence strategic decision-making?
What were some of Rachel Knight's key projects at L.E.K. Consulting that set the stage for her career in business development?
How does Rachel Knight envision the future of drug development and commercialization in the life sciences sector?
Rachel Knight
Add to my network

Location

Los Angeles Metropolitan Area